Graham Capital Management »

Pmv Pharmaceuticals shares owned by Graham Capital Management

Quarter-by-quarter ownership of Pmv Pharmaceuticals (PMVP) shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in Pmv Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pmv Pharmaceuticals held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pmv Pharmaceuticals by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $71k 23k 3.10
2022-09-30 $335k 28k 11.88

More positions owned by Graham Capital Management

Ishares Tr Russell 2000 Etf (IWM)
Microstrategy Cl A New Put Option (MSTR)
Zillow Group Note 0.750% 9/0 (Principal)
Microstrategy Note 0.750%12/1 (Principal)
Permian Resources Corp Note 3.250% 4/0 (Principal)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Tilray Brands Note 5.200% 6/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Transocean Deb 4.000%12/1 (Principal)
Bill Holdings Note 12/0 (Principal)
Opko Health Note 4.500% 2/1 (Principal)
Bloom Energy Corp Note 2.500% 8/1 (Principal)
Maxeon Solar Technologies Lt SHS Call Option (MAXN)
Maxeon Solar Technologies Lt Note 6.500% 7/1 (Principal)
Zscaler Note 0.125% 7/0 (Principal)

View all positions for Graham Capital Management

Top funds holding Pmv Pharmaceuticals

OrbiMed Advisors
Jpmorgan Chase & Co
Arrowpoint Asset Management
Euclidean Capital
Vanguard Group
Partner Fund Management
Bank of America Corporation
BML Capital Management
Citadel Advisors
Goldman Sachs Group
Point72 Asset Management
Federated Investors
Vontobel Holding
EcoR1 Capital
Dimensional Fund Advisors

View all funds holding Pmv Pharmaceuticals